Submission deadline: 31 August 2020
Fecal microbiota transplantation (FMT) has been used for the treatment of recurrent Clostridioides difficile infection (CDI) and diseases beyond CDI, such as ulcerative colitis, Crohn’s disease, hepatic encephalopathy, and other dysbiosis related diseases. The latest progress on FMT mainly involves washed microbiota transplantation, newly developed delivery of microbiota, emerging clinical benefits and the adverse events of microbiota transplantation. However, the regulation and clinical application of FMT varies among different countries. Therefore, it is very important to focus on the frontlines of FMT.
In this special issue titled, “Safety, methodology and pilot studies in microbiota transplantation”, submission of original papers, case reports, review articles, or opinions concerning the topics mentioned above, and related fields, are welcomed. All accepted articles will be published ahead of time.
Prof. Faming Zhang
Nanjing Medical University, Nanjing, China
Submit your paper here
Register (if you are a first-time user)
Click “submit new manuscript”
Select Special Issue article type name “VSI:microbiota transplantation” during the submission process
Follow the step-by-step guide to completing the submission procedure
Please follow the journal Guide for Authors when preparing your manuscript.
Publishing in Medicine in Microecology provides many author benefits, including Article Publishing Charge (APC) waivers for all accepted manuscripts submitted by 31 December 2020.